Maintenance of Platelet Inhibition With Cangrelor

PHASE2CompletedINTERVENTIONAL
Enrollment

221

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

July 31, 2011

Conditions
Acute Coronary Syndrome (ACS)
Interventions
DRUG

cangrelor

OTHER

Placebo

Placebo IV infusion administered in the same fashion as the active study drug in order to maintain the blind in the study.

Trial Locations (1)

92037

Scripps Clinic / Scripps Green Hospital, La Jolla

Sponsors
All Listed Sponsors
lead

The Medicines Company

INDUSTRY